Literature DB >> 14648764

Conformational and biological characterization of human parathyroid hormone hPTH(1-34) analogues containing beta-amino acid residues in positions 17-19.

E Schievano1, S Mammi, E Carretta, N Fiori, M Corich, A Bisello, M Rosenblatt, M Chorev, E Peggion.   

Abstract

The N-terminal 1-34 fragment of parathyroid hormone (PTH) elicits the full spectrum of bone-related biological activities of the intact native sequences. It has been suggested that the structural elements essential for bioactivity are two helical segments located at the N-terminal and C-terminal sequences, connected by hinges or flexible points around positions 12 and 19. In order to assess the relevance of the local conformation around Gly(18) upon biological function, we synthesized and characterized the following human (h) PTH(1-34) analogues containing beta-amino acid residues: [analogues: see text]. Biological activity and binding affinity of analogue I are one order of magnitude lower than those of the parent compound. In analogue II, both binding affinity and biological activity are partially recovered. Analogues III and V have no binding affinity and very low biological activity. Both bioactivity and binding affinity are partially recovered in analogue IV. The conformational properties of the analogues in aqueous solution containing dodecylphosphocholine micelles were studied by CD, 2D-nuclear magnetic resonance and molecular dynamics calculations. The results confirmed the presence in all analogues of two helical segments located at the N-terminal and C-terminal sequences. The insertion of beta-amino acid residues around position 18 does not cause appreciable conformational differences in the five analogues. The differences in biological activity and binding affinity among the five analogues cannot be related to structural differences in the membrane mimetic environment reported in this study. Our results stress the importance of the side-chain functionalities in the sequence 17-19 for biological function. Copyright 2003 Wiley Periodicals, Inc. Biopolymers 70: 534-547, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648764     DOI: 10.1002/bip.10508

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  8 in total

1.  Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 Sequence.

Authors:  Anamika Singh; Srinivasa R Tala; Viktor Flores; Katie Freeman; Carrie Haskell-Luevano
Journal:  ACS Med Chem Lett       Date:  2015-04-08       Impact factor: 4.345

2.  Impact of Substitution Registry on the Receptor-Activation Profiles of Backbone-Modified Glucagon-like Peptide-1 Analogues.

Authors:  Brian P Cary; Marlies V Hager; Samuel H Gellman
Journal:  Chembiochem       Date:  2019-09-20       Impact factor: 3.164

3.  Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.

Authors:  Marlies V Hager; Lachlan Clydesdale; Samuel H Gellman; Patrick M Sexton; Denise Wootten
Journal:  Biochem Pharmacol       Date:  2017-03-29       Impact factor: 5.858

4.  Backbone modification of a polypeptide drug alters duration of action in vivo.

Authors:  Ross W Cheloha; Akira Maeda; Thomas Dean; Thomas J Gardella; Samuel H Gellman
Journal:  Nat Biotechnol       Date:  2014-06-15       Impact factor: 54.908

5.  Effects of Single α-to-β Residue Replacements on Structure and Stability in a Small Protein: Insights from Quasiracemic Crystallization.

Authors:  Dale F Kreitler; David E Mortenson; Katrina T Forest; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2016-05-12       Impact factor: 15.419

6.  Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.

Authors:  Ross W Cheloha; Bingming Chen; Niyanta N Kumar; Tomoyuki Watanabe; Robert G Thorne; Lingjun Li; Thomas J Gardella; Samuel H Gellman
Journal:  J Med Chem       Date:  2017-10-24       Impact factor: 7.446

7.  Use of Backbone Modification To Enlarge the Spatiotemporal Diversity of Parathyroid Hormone Receptor-1 Signaling via Biased Agonism.

Authors:  Shi Liu; Frederic G Jean-Alphonse; Alex D White; Denise Wootten; Patrick M Sexton; Thomas J Gardella; Jean-Pierre Vilardaga; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2019-09-09       Impact factor: 15.419

8.  A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo.

Authors:  Lisa M Johnson; Stacey Barrick; Marlies V Hager; Amanda McFedries; Edwin A Homan; Mary E Rabaglia; Mark P Keller; Alan D Attie; Alan Saghatelian; Alessandro Bisello; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2014-09-05       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.